F. de Wolf

Overview

Best Publications

• Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

  Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  1035
  Citations

• Future challenges for clinical care of an ageing population infected with HIV: a modelling study

  Mikaela Smit;Kees Brinkman;Suzanne Geerlings;Colette Smit

  1017
  Citations

• Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

  M. Tersmette;R. A. Gruters;F. De Wolf;R. E. Y. De Goede

  969
  Citations

• Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

  M. Tersmette;J. M. Lange;R. E. de Goede;F. de Wolf

  887
  Citations

• Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

  F Miedema;A J Petit;F G Terpstra;J K Schattenkerk

  639
  Citations

• Late presentation of HIV infection: a consensus definition

  A Antinori;T Coenen;D Costagiola;N Dedes

  627
  Citations

• The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

  Maile Ray;Roger Logan;Jonathan A C Sterne;Sonia Hernández-Díaz

  580
  Citations

• Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

  Ard I. van Sighem;Luuk A. J. Gras;Peter Reiss;Kees Brinkman

  537
  Citations

• Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis

  Christophe Fraser;T. Déirdre Hollingsworth;Ruth Chapman;Frank de Wolf

  514
  Citations

• Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

  J. M. A. Lange;D. A. Paul;H. G. Huisman;F. De Wolf

  500
  Citations

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  492
  Citations

• Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.

  H. Schuitemaker;N. A. Kootstra;R. E. Y. De Goede;F. De Wolf

  471
  Citations

• T cell telomere length in HIV-1 infection: No evidence for increased CD4(+) T cell turnover

  Katja C. Wolthers;G. Bea;A. Wisman;Sigrid A. Otto

  421
  Citations

• Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection

  A.M. de Roda Husman;M. Koot;M.T.E. Cornelissen;I.P.M. Keet

  390
  Citations

• Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

  G Chêne;J A C Sterne;M May;D Costagliola

  355
  Citations

• When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study

  Lauren E Cain;Roger Logan;James M Robins;Jonathan A C Sterne

  330
  Citations

• HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

  May Mt;Sterne Ja;Costagliola D;Sabin Ca

  318
  Citations

• Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

  J.M. Prins;S. Jurriaans;van R.M.E. Praag;H. Blaak

  306
  Citations

• Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

  Zwahlen M;Harris R;May M

  275
  Citations

• Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine

  D W Notermans;S Jurriaans;F de Wolf;N A Foudraine

  267
  Citations

• Mortality and progression to AIDS after starting highly active antiretroviral therapy.

  van Ai Sighem;van de Ma Mark Wiel;AC Ghani;M Jambroes

  261
  Citations

• Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS

  C.A. van Baalen;O. Pontesilli;R.C. Huisman;A.M. Geretti

  255
  Citations

• Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam.

  J. A. R. van den Hoek;H. J. A. van Haastrecht;J. Goudsmit;F. de Wolf

  250
  Citations

• CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

  Luuk Gras;Anouk M Kesselring;James T Griffin;Ard I van Sighem

  232
  Citations